Alamar Biosciences, Inc.
ALMRNasdaqCIK 2104204TechnologyFiscal year ends Dec 31
Latest reported revenue, Q2 FY2026$29.4mRevenue, Q2 FY2026, three months to 2026-06-30$29.4m. XBRL concept
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 11, 2026.Latest quarter: Q2 FY2026
Three months to Jun 30, 2026, against the same quarter a year earlier.
- Revenue$29.4mRevenue, Q2 FY2026, three months to 2026-06-30$29.4m. XBRL concept
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure+82.1% on a year earlier - Gross margin60.2%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $17.7m. XBRL concept
us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Revenue: $29.4m. XBRL conceptus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure+7.1 pts on a year earlier - Operating margin−46.0%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$13.5m. XBRL concept
us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Revenue: $29.4m. XBRL conceptus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure+3.0 pts on a year earlier - Net margin−44.9%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$13.2m. XBRL concept
us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Revenue: $29.4m. XBRL conceptus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure−1.4 pts on a year earlier - Diluted EPS−$0.22Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.22 per share. XBRL concept
us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure+64.5% on a year earlier - Free cash flow−$15.0mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$11.3m. XBRL concept
us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-343003. Derived: 6-month figure less the 3-month figure.Capital expenditure: $3.6m. XBRL conceptus-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-343003. Derived: 6-month figure less the 3-month figure.Report this figure−18.4% on a year earlier
Last eight quarters
Full statements| Line item | Unit | period not labelled2025-03-31 | period not labelled2025-06-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 | Shape over the periods |
|---|---|---|---|---|---|---|
| Revenue | $m | 13.1Revenue, period not labelled, three months to 2025-03-31$13.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure | 16.2Revenue, period not labelled, three months to 2025-06-30$16.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure | 26.0Revenue, Q1 FY2026, three months to 2026-03-31$26.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure | 29.4Revenue, Q2 FY2026, three months to 2026-06-30$29.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure | |
| Gross margin | % | 48.8%Gross margin, period not labelled, three months to 2025-03-31. gross profit / revenueGross profit: $6.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Revenue: $13.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure | 53.1%Gross margin, period not labelled, three months to 2025-06-30. gross profit / revenueGross profit: $8.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Revenue: $16.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure | 55.5%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $14.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Revenue: $26.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure | 60.2%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $17.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Revenue: $29.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure | |
| Operating margin | % | (65.3%)Operating margin, period not labelled, three months to 2025-03-31. operating income / revenueOperating income: −$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Revenue: $13.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure | (49.0%)Operating margin, period not labelled, three months to 2025-06-30. operating income / revenueOperating income: −$7.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Revenue: $16.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure | (47.4%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$12.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Revenue: $26.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure | (46.0%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$13.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Revenue: $29.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure | |
| Net margin | % | (58.5%)Net margin, period not labelled, three months to 2025-03-31. net income / revenueNet income: −$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Revenue: $13.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure | (43.5%)Net margin, period not labelled, three months to 2025-06-30. net income / revenueNet income: −$7.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Revenue: $16.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure | (81.9%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$21.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Revenue: $26.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure | (44.9%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$13.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Revenue: $29.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure | |
| Diluted EPS | $ per share | (0.68)Diluted EPS, period not labelled, three months to 2025-03-31−$0.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure | (0.62)Diluted EPS, period not labelled, three months to 2025-06-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure | (1.74)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure | (0.22)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343003.Report this figure | |
| Free cash flow | $m | (13.6)Free cash flow, period not labelled, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$13.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Capital expenditure: $554.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure | (12.6)Free cash flow, period not labelled, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$11.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-343003. Derived: 6-month figure less the 3-month figure.Capital expenditure: $753.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-343003. Derived: 6-month figure less the 3-month figure.Report this figure | (20.9)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$20.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Capital expenditure: $600.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001193125-26-213424.Report this figure | (15.0)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$11.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-343003. Derived: 6-month figure less the 3-month figure.Capital expenditure: $3.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-343003. Derived: 6-month figure less the 3-month figure.Report this figure |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Last five fiscal years
| Line item | Unit | Shape over the periods |
|---|---|---|
| Revenue | $ | |
| Gross margin | % | |
| Operating margin | % | |
| Net margin | % | |
| Diluted EPS | $ per share | |
| Free cash flow | $ |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Insider purchases and sales
All insider transactionsThe last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-28 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 8,450 | $33.11 | $279.8k | Form 4 |
| 2026-10-28 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 9,846 | $32.47 | $319.7k | Form 4 |
| 2026-10-28 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 7,058 | $33.11 | $233.7k | Form 4 |
| 2026-10-28 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 8,224 | $32.47 | $267.0k | Form 4 |
| 2026-10-28 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 30,249 | $33.11 | $1.0m | Form 4 |
| 2026-10-28 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 35,248 | $32.47 | $1.1m | Form 4 |
| 2026-10-28 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 814 | $33.11 | $27.0k | Form 4 |
| 2026-10-28 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 948 | $32.47 | $30.8k | Form 4 |
| 2026-10-27 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 4,226 | $31.88 | $134.7k | Form 4 |
| 2026-10-27 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 9,791 | $31.33 | $306.8k | Form 4 |
| 2026-10-27 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 1,386 | $30.33 | $42.0k | Form 4 |
| 2026-10-27 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 3,531 | $31.88 | $112.6k | Form 4 |
| 2026-10-27 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 8,178 | $31.33 | $256.2k | Form 4 |
| 2026-10-27 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 1,157 | $30.33 | $35.1k | Form 4 |
| 2026-10-27 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 15,131 | $31.88 | $482.4k | Form 4 |
| 2026-10-27 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 35,049 | $31.33 | $1.1m | Form 4 |
| 2026-10-27 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 4,960 | $30.33 | $150.4k | Form 4 |
| 2026-10-27 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 408 | $31.88 | $13.0k | Form 4 |
| 2026-10-27 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 943 | $31.33 | $29.5k | Form 4 |
| 2026-10-27 | Qiming Corporate GP VI, Ltd.10% owner | Sale | 134 | $30.33 | $4.1k | Form 4 |
Funds that report holding it
All fundsFrom each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|
| Sands Capital Alternatives, LLC | 2026-06-30 | $114.6m | 4,230,926 | New+4,230,926 | |
| SAMSARA BIOCAPITAL, LLC | 2026-06-30 | $67.2m | 2,480,310 | New+2,480,310 | |
| ARK Investment Management LLC | 2026-06-30 | $37.2m | 1,373,959 | New+1,373,959 | |
| BRAIDWELL LP | 2026-06-30 | $29.4m | 1,083,983 | New+1,083,983 | |
| ALLIANCEBERNSTEIN L.P. | 2026-06-30 | $27.2m | 1,003,077 | New+1,003,077 | |
| HHLR ADVISORS, LTD. | 2026-06-30 | $25.9m | 956,462 | New+956,462 | |
| BlackRock, Inc. | 2026-06-30 | $24.7m | 911,445 | New+911,445 | |
| MILLENNIUM MANAGEMENT LLC | 2026-06-30 | $23.5m | 865,764 | New+865,764 | |
| FMR LLC | 2026-06-30 | $22.5m | 829,424 | New+829,424 | |
| PURA VIDA INVESTMENTS, LLC | 2026-06-30 | $20.5m | 755,909 | New+755,909 |
Recent filings
All 59 filingsReports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0116:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-378360 |
| 2026-08-1120:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-343003 |
| 2026-08-1016:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342378 |
| 2026-07-1516:04 ET | 8-K | 8.01 Other events | 0001193125-26-304736 |
| 2026-07-0716:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001875620-26-000010 |
| 2026-05-0808:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-213424 |
| 2026-05-0808:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-213379 |
| 2026-04-2316:24 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-173780 |
| 2026-04-2313:57 ET | SCHEDULE 13D | Ownership report, active investor | 0001875620-26-000007 |
| 2026-04-2016:02 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-163921 |
Latest annual report
No annual report is in coverage for this company.
Forecast league
Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter
About the filer
- CIK
- 2104204
- Tickers
- ALMR
- Exchange
- Nasdaq
- SIC code
- 3826 Laboratory Analytical Instruments
- Sector
- Technology
- Fiscal year ends
- Dec 31
- Incorporated in
- DE
- Filer category
- <br>Emerging growth company
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:10 ET. Listed shows no prices and gives no investment advice.